{"SPADE_N_07191": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_07191", "Peptide Name": "P144", "Source": "TGFβ Receptor", "Family": "", "Gene": "Not found", "Sequence": "TSLDASIIWAMMQN", "Sequence Length": 14, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "TGFβ", "Linear/Cyclic": "", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C68H109N17O22S2", "Mass": 1580.82, "PI": 4.05, "Net Charge": -1, "Hydrophobicity": 0.46, "Half Life": "Mammalian:7.2 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Anti-angiogenic peptides for cancer therapeutics", "Pubmed ID": "21470139", "Reference": "Curr Pharm Biotechnol. 2011 Aug;12(8)1101-32.", "Author": "Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21470139"}], "Frequent Amino Acids": "AIM", "Absent Amino Acids": "CEFGHKOPRUVY", "Basic Residues": 0, "Acidic Residues": 1, "Hydrophobic Residues": 8, "Polar Residues": 7, "Positive Residues": 0, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06406", "Similarity": 1.0, "Sequence": "TSLDASIWAMMQNA"}, {"SPADE_ID": "SPADE_UN_08983", "Similarity": 1.0, "Sequence": "MQNEEGKTVDLYVPRKCSATNRIITAKDHASVQINIGHLDANGLYDGHFTTFALSGFVRAQGDADSSLDRLRQKKKADIKQ"}, {"SPADE_ID": "SPADE_UN_09454", "Similarity": 1.0, "Sequence": "MQNEEGKTVDLYVPRKCSATNRIITAKDHASVQINIGHLDANGLYDGHFTTFALSGFVRAQGDADSSLDRLWQKKKAEIKQ"}]}}}